增强人们的免疫系统是构建人类命运共同体的重要环节，为贯彻落实两会精神，深化学习宣传习近平总书记重要讲话，立足新发展、新理念，构建新格局，推动形成以国内大循环为主体、国内国际双循环相互促进的新发展格局，为百姓提供更加优质的健康产品，在欧美同学会企业家联谊会的支持下，由协合生物集团、协合国际生物科技（广州）有限公司共同主办的协合超抗原支持国际免疫项目新闻发布会于2021年 4 月 8日下午在中国·北京中国大饭店举行。
Theme: Building a human immune barrier and building a human health community
Purpose: Seeking the health and well-being of all man-kind.
Press conference of the Global Immunization Allian
Enhancing people’s immune system is an important link in building a community with a shared future for mankind. In order to implement the spirit of the two sessions, deepen the study and publicity of General Secretary Xi Jinping’s important speech, build a new pattern based on new developments and new ideas, and promote the formation domestically. The new development pattern of mutual promotion of the international double cycle provides the people with better quality health products. With the support of the Western Returned Scholars Association Entrepreneur Alliance, co-sponsored by Xiehe Biological Group and Xiehe International Biotechnology (Guangzhou) Co., Ltd. The press conference of Concord Superantigen Support International Immunization Project will be held on the afternoon of April 8, 2021 at China World Hotel, in Beijing, China.
More than a hundred guests from the medical profession and business representatives were invited to attend the conference. The meeting received strong support from China Health Industry Investment Fund, U.S.-China Capital INC. and other organizations, and jointly with People's Daily, Guangming.com, China.com, Chinanews.com, Tencent.com, Macau Legal Daily and many other media witnessed this important event.
The theme of the press conference was "Building a human immune barrier and building a human health community". Participants listened to biologists and medical scientists on the global pandemic, various challenges in fighting the pandemic, and various effective immunization measures. Insights related to the current pandemic, such as the damage of the virus to the human immune system, the long-term recovery of patients with new strain of covid-19. Speaking upon how to build a long-term immune mechanism by improving immunity, more effectively respond to the current pandemic, and better helping everyone to fight in a timely and effective manner against major infectious disease crises caused by virus mutations and new pathogenic microorganisms that may appear in the future. The meeting focused on the mentioned topics above.
As of March 31, the number of people infected with Covid-19 reached 127 million globally. This sudden infectious disease crisis has had an unprecedented and profound impact on the world’s economy and people’s livelihoods, prompting humans to think deeply about how to learn from the experience of the prevention and control of infectious diseases. Lessons are learned from a strategic perspective of the significance of improving human immunity, building a firewall for human health, and effectively responding to major infectious diseases that may appear in the future.
Professor Dong Baowei, a first-level professor of technology and a doctoral supervisor of the Chinese People’s Liberation Army, concluded that Covid-19 has the following characteristics: outbreak, rapid transmission, diverse transmission routes, rapid virus mutation, damage to the human immune system, and long recovery period, These conditions can recur often.
From a long-term perspective, Professor Shi Ming, deputy dean and doctoral supervisor of the School of Public Health of Guangdong Medical College, believes that improving immunity is the real firewall for humans to fight similar infectious diseases. Systematically improving the immunity of all mankind will help mankind face the threats posed by various infectious diseases in the future.
The famous medical scientist General Dong Baowei quoted the opinion of Professor Powell of Harvard University, “80% of human diseases are related to the degeneration and decline of the immune system. Although various diseases appear to be different on the surface, their recovery process is surprisingly similar. It is the result of immune adjustment".
Professor Shi Ming, a public health expert, quoted the view of Japan’s "Immune Revolution": “95% of human diseases are related to low immunity. If immunity is increased by 30%, the incidence of various tumors will be reduced by 50%, and the incidence of various infectious diseases will be reduced by 50%. The incidence rate is reduced by 50%, and the human body function is technically 10 years younger."
A survey by the World Health Organization shows that only 5% of humans are truly healthy, less than 20% of people have been diagnosed with diseases, and more than 75% of people are in sub-healthy conditions. The sub-health state is the state of low immunity of the human body to varying degrees.
At this press conference, biologists from Xiehe Bio Group introduced an original Chinese biological drug "Xiehe Superantigen Product Aureus Staphyllin Injection" and BM oral liquid to the world.
According to the biologists of Xiehe, superantigen is not only a substance that can activate immune cells, but also a kind of "super" immune phenomenon, and it is also a recognized theory in modern immunology.
Superantigens are substances that can efficiently activate immune cells and release a large number of immune factors to activate the human immune system. Such substances can activate 10-20% in a short time at a very low dose (in nanograms). T lymphocytes, NK cells, B cells and other immune cells, compared with common antigens such as the familiar Ganoderma lucidum, Cordyceps, ginseng, etc., activate immune cells 2000-50000 times more efficiently.
Staphylococcus aureus enterotoxin protein is recognized as a superantigenic substance, and staphylococcus aureus injection developed by Concord Biogroup is currently the only superantigen drug derived from Staphylococcus aureus in the world. Other international counterparts have already started related research four to seven years ago.
According to on-site medical experts, Synergistic Superantigen drugs can significantly increase the level of T lymphocytes such as CD3, CD4, CD8, etc., and can also significantly increase the level of NK cells, and can promote immunity including interleukin, tumor necrosis factor, interferon, etc. The release of factors can play the role of anti-tumor, anti-virus and other disease prevention and disease resistance.
Professor Chen Juyu, Chairman of the Board of Xiehe Biologics Group, said that Xiehe superantigen drugs have been used in China for 20 years. They have reliable clinical evidence for improving immunity and have few side effects. During SARs, H1N1, MERs and other infectious diseases and during the current pandemic, there were a large number of drug donations, and good feedback was obtained. In particular, the research and development of oral preparations can not only exert its super-antigen and super-immune effect, but also avoid immunosuppression, and is conducive to large-scale and long-term use. In short, improving immunity will not only help the human body fight against various pathogenic microorganisms, fight tumors and other major disease threats, but also help recover from illness and improve human physiology!
Mr. Liu Le, chairman of Xiehe International Biotechnology (Guangzhou) Co., Ltd., said that Xiehe Guangzhou’s mission is to initiate and promote the “Global Immunization Alliance” internationally. The company will cooperate with pharmaceutical companies, R&D institutions, and management institutions in various countries. Work together to promote immunity-improving products-superantigens to the world, and jointly promote the global human immunization cause, through the "Global Immunization Alliance", to seek global human health and well-being, especially to promote the improvement of the health of people in poverty-stricken areas.
Mr. Xu Changdong, President of the Western Returned Scholars Association Entrepreneur Alliance （WRSAEA）, said that the WRSAEA has many outstanding members in the biopharmaceutical and medical fields around the world. The WRSAEA supports Xiehe Biological Group and Xiehe International Biology. Science and Technology (Guangzhou) Co., Ltd. organized this press conference to unite people of insight around the world to jointly build a human immune barrier and build a long-term immune mechanism to build a human health community. This agenda responds to the actions of General Secretary Xi Jinping. The call to build a community with a shared future for mankind will promote China's original immunological biological drugs to the world, and contribute to supporting the global fight against Covid-19.